Organization Profile

Related Organization(s)

You just read:

Lilly and Incyte Announce Patients Treated with Baricitinib Demonstrated Significant Improvement in Signs and Symptoms of Rheumatoid Arthritis Compared with Methotrexate

News provided by

Eli Lilly and Company

Nov 07, 2015, 19:30 ET